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Summary
Brain pericytes play a critical role in blood vessel stability
and blood–brain barrier maturation. Despite this, how brain
pericytes function in these different capacities is only
beginning to be understood. Here we show that the forkhead
transcription factor Foxc1 is expressed by brain pericytes
during development and is critical for pericyte regulation of
vascular development in the fetal brain. Conditional deletion of
Foxc1 from pericytes and vascular smooth muscle cells leads to
late-gestation cerebral micro-hemorrhages as well as pericyte
and endothelial cell hyperplasia due to increased proliferation
of both cell types. Conditional Foxc1 mutants do not have
widespread defects in BBB maturation, though focal
breakdown of BBB integrity is observed in large, dysplastic
vessels. qPCR profiling of brain microvessels isolated from
conditional mutants showed alterations in pericyte-expressed
proteoglycans while other genes previously implicated in
pericyte–endothelial cell interactions were unchanged.
Collectively these data point towards an important role for
Foxc1 in certain brain pericyte functions (e.g. vessel
morphogenesis) but not others (e.g. barriergenesis).
 2013. Published by The Company of Biologists Ltd. This is an
Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/
licenses/by/3.0), which permits unrestricted use, distribution
and reproduction in any medium provided that the original
work is properly attributed.
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Introduction
During neural development appropriate growth and maturation of
the brain vasculature is essential to meet increasing metabolic
needs and to establish a barrier between the brain and potentially
damaging agents circulating in the blood. An important step in
brain angiogenesis is the association of pericytes with forming
brain capillaries. Responding to platelet-derived growth factor-B
(PDGFB) released by endothelial cells (ECs), PDGF receptor-b
(PDGFrb) expressing pericytes home towards and spread along the
vessel surface (for a review, see Armulik et al., 2011). Deletion of
either PDGFB or PDGFrb results in reduction in pericyte
investment of the vasculature in several organs, including the
brain and retina (Bjarnega˚rd et al., 2004; Hellstro¨m et al., 2001;
Lindahl et al., 1997). In the fetal brain, loss of pericyte coverage
does not overtly impact vessel patterning, however, there are
significantly more endothelial cells (ECs) per vessel (hyperplasia),
and vessels are susceptible to hemorrhage (Hellstro¨m et al., 2001;
Lindahl et al., 1997). Moreover, pericytes play an essential role in
the formation and maintenance of the blood brain barrier (BBB)
and establishment of the neurovascular unit. Pericyte-deficient
mutants (PDGFB-null or hypomorph and PDGFrb-null) display
systemic brain vascular leak and, postnatally, fail to establish
proper polarity of the astrocyte endfeet (Armulik et al., 2010;
Daneman et al., 2010b). The defects in the fetal brain vasculature
of pericyte-deficient mutants provide compelling evidence that
pericytes are critical for stabilization and maturation of the neural
vascular plexus.
While it is clear that brain pericytes have critical functions in
both the fetal and adult brain vasculature (for reviews, see
(Bergers and Song, 2005; Gaengel et al., 2009; Winkler et al.,
2011), there is less known about how they function in these
different capacities. In vitro, pericytes inhibit EC proliferation in
a cell contact-dependent manner (Orlidge and D’Amore, 1987)
and this is due at least in part to activation of transforming growth
factor-b1 (TGFb1) (Antonelli-Orlidge et al., 1989). Pericyte-
derived TGFb1 also plays a role in BBB-induction in pericyte–
EC co-culture systems (Dohgu et al., 2005). Pericytes are a
potentially important source of vascular endothelial growth factor
(VEGF); retinal pericytes express VEGF and pericyte derived-
VEGF is an important pro-survival cue for cultured ECs (Darland
et al., 2003). Pericytes are also a purported source of
angiopoietin-1 (Sundberg et al., 2002), the agonist for the
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endothelial Tie2 receptor critical for vessel stabilization during
development (Suri et al., 1996; Suri et al., 1998; Thurston et al.,
1999). Collectively this evidence suggests that cell–cell contact
and production of diffusible ligands are a major part of how brain
pericytes function in vivo. Up to this point, however, no
transcription factors with the potential to influence multiple
signaling pathways in pericytes have been identified.
Foxc1, a forkhead transcription factor expressed by a variety of
mesenchymal tissues, is particularly important for development
of head structures. Foxc1 hypomorphs or null mouse mutants
have moderate to severe defects in eye, craniofacial and brain
development (Aldinger et al., 2009; Kume et al., 2000;
Siegenthaler et al., 2009; Smith et al., 2000; Zarbalis et al.,
2007; Kume et al., 1998). Foxc1-null mutants have also been
reported to have considerable brain hemorrhaging toward the end
of gestation that is largely limited to the forebrain region
(Gru¨neberg, 1943; Kume et al., 1998). Expression of Foxc1 has
been localized to the brain endothelium (Kume et al., 1998) and
we have previously shown that Foxc1 is expressed in perivascular
cells in the brain and meninges (Zarbalis et al., 2007). Here we
show more definitively that Foxc1 is expressed by brain pericytes
and that it is essential for normal pericyte function in the
developing brain. Specifically, conditional deletion of Foxc1
from pericytes and vascular smooth muscle cells (vSMCs) leads
to alterations in both brain pericyte and EC proliferation and the
appearance of late-gestation brain micro-hemorrhage.
Results
Foxc1 is expressed by pericytes and vSMCs in the fetal brain
There are numerous Foxc1+ cells immediately adjacent to large
vessels in the meninges and associated with small vessels in the
brain parenchyma, which we suspected were pericytes (Zarbalis
et al., 2007). Foxc1 is expressed by the meningeal cells and, like
forebrain pericytes, these cells are derived from the cranial neural
crest (Etchevers et al., 2001). On the other hand, Foxc1 and its
close homologue Foxc2 are important for early EC specification
and vascular development in the early embryo (De Val et al.,
2008; Seo et al., 2006). To definitively identify the Foxc1
expressing cell type in the brain vasculature, we used markers of
ECs (PECAM) and pericyte/vSMC (PDGFrb, smooth muscle
actin-a) in conjunction with Foxc1 immunostaining. At E14.5,
Foxc1+ cells were found on the outside of PECAM+ blood
vessels in the brain (Fig. 1A), the characteristic location for
pericytes. In addition, Foxc1+ nuclei were observed within the
vessel which is consistent with expression by endothelial cells
(Fig. 1A). Pericyte and vSMCs labeled by PDGFrb and smooth
muscle actin-a, respectively, had Foxc1+ nuclei (Fig. 1B,C),
indicating that Foxc1 is expressed by brain pericytes and vSMCs.
As with PECAM, we observed Foxc1+ cells within the vessel
lumen of blood vessels, presumable ECs, outlined with PDGFrb
(Fig. 1B). Foxc2, a close homologue of Foxc1, is frequently co-
expressed with Foxc1 and double-KO studies indicate that these
two genes have redundant functions developmentally (Kume et
al., 2000; Kume et al., 2001; Seo et al., 2006). Immunostaining
for Foxc2 revealed expression in some cells in the meninges but,
unlike Foxc1, there was no expression associated with the
vasculature in the brain (Fig. 1D,E). This suggests that Foxc2
cannot compensate for Foxc1 activity in brain pericytes and
vSMCs, thus making it possible that loss of Foxc1 alone could
negatively impact pericyte function.
Increased pericyte proliferation in Foxc1 mutant brains
Reduction in pericyte coverage of blood vessels leads to brain
vascular defects and micro-hemorrhages (Hellstro¨m et al., 2001).
Foxc1 null mice (Foxc1-LacZ) and Foxc1 hypomorph mutants
(Foxc1-hith) have developmental brain hemorrhages (Kume et
al., 1998; Zarbalis et al., 2007). While these vascular defects are
more severe than what would be expected with pericyte loss, it is
possible that alterations in pericyte coverage might contribute to
the Foxc1 brain vascular phenotype. Using PDGFrb expression to
visualize pericyte sheaths around cerebral vessels at E14.5, it
appeared that pericyte coverage was comparable between
wildtype (WT), Foxc1h/h and Foxc1l/l mutants (Fig. 2A–C).
Quantification of pericyte coverage using a nuclear marker of
brain pericytes and meningeal cells, Zic-1 (Daneman et al.,
2010b; Inoue et al., 2008), revealed an increase in pericyte nuclei
per vessel length in Foxc1 mutants though it was not significantly
different from WT (Fig. 2D–G). Interestingly, pericyte
proliferation (as determined by BrdU incorporation) was
significantly (P,0.05) increased in both types of Foxc1
mutants (Fig. 3D–F,H). Changes in pericyte proliferation may
reflect an inability to properly respond to differentiation signals
controlling pericyte expansion and suggests that although the
pericytes are present in Foxc1 mutants, they may not be
functioning properly.
Focal brain hemorrhage and increased pericyte number in
pericyte conditional Foxc1 mutants
Since Foxc1 mutants have significant defects in both brain and
vascular development, it is difficult to determine from these
mutants the cell-autonomous role of Foxc1 in brain pericytes or
ECs. Conditional deletion of Foxc1 from ECs causes no overt
brain vascular phenotype in the adult animal (Hayashi and Kume,
2008). Thus, Foxc1 is unlikely to have a significant, cell-
autonomous role in brain ECs. To address whether Foxc1 is
important for brain pericyte function during development, we
Fig. 1. Foxc1 is expressed by brain pericytes. (A) Foxc1 (green) and PECAM
(red) co-immunolabeling of a cerebral vessel at E14.5. Arrowhead indicates
Foxc1+ cells immediately adjacent to the PECAM+ vessel. Arrows indicate
Foxc1+ cell in the inner lumen of the PECAM+ vessel. (B) Arrowheads
indicate Foxc1 (green) and PDGFrb (red; B) or SMA-a (red; C) co-labeled
pericytes around the outside of cerebral blood vessels. Arrows indicate Foxc1+
cell in the inner lumen of the vessel cross-section. (D,E) Foxc1 (D) and Foxc2
(E) in the meninges and adjacent cortex at E14.5. Laminin (red) labels cerebral
vessels. Scale bars: 25 mm (A–C); 50 mm (D,E).
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used the PDGFrb-cre line, previously shown to recombine all
pericytes and vSMCs in the brain by E10.5 (Stenzel et al., 2009),
and a Foxcl-flox allele (Hayashi and Kume, 2008; Sasman et al.,
2012) to conditionally ablate Foxc1 from this cell population. To
confirm knockdown of Foxc1 expression in brain pericytes, we
performed RT-PCR for Foxc1 transcript on cDNA from control
meninges (high expression of Foxc1) or microvessels (contain
both ECs and pericytes) isolated from control brains or PDGFrb-
cre; Foxc1fl-fl brains (Fig. 3A). Foxc1 transcript is appreciable
lower in PDGFrb-cre; Foxc1fl-fl microvessels; the residual
expression is likely Foxc1 in ECs.
PDGFrb-cre;Foxc1fl-fl mutants were similar in size to
littermate controls at E18.5 (Fig. 3B) but died at birth. Thus
our analysis of the brain vasculature was limited to the prenatal
period. At E18.5, PDGFrb-cre;Foxc1fl-fl brains had small, focal
hemorrhages in the cerebral cortex not observed in a littermate
control (Fig. 3C–E). Although all PDGFrb;Foxc1fl-fl examined
displayed vascular defects in the forebrain, the number and size
of obvious hemorrhages varied from mild (Fig. 3D) to more
severe (Fig. 3E). Glut-1 immunostaining of E18.5 cortices
revealed a relatively normal vascular pattern in PDGFrb-
cre;Foxc1fl-fl but abnormally enlarged vessels and Glut-1+ red
blood cells in the neural parenchyma indicating hemorrhage
distinguished the mutants from littermate controls (Fig. 3F,G).
Indeed, mean cerebral vessel diameter was significantly
increased in PDGFrb-cre;Foxc1fl-fl mutants but cerebral vessel
density was unaltered (Fig. 3H). Isolectin B4 (IB4) staining,
which labels both blood vessels and microglia, highlighted the
amoeboid morphology of activated microglia around the
hemorrhage site in the PDGFrb-cre;Foxc1fl-fl cortex (Fig. 3G);
activated microglia are characteristic of an inflammatory response,
presumably caused by the hemorrhage. We also observed
upregulation of endothelial ICAM-1 in E18.5 PDGFrb-
cre;Foxc1fl-fl cerebral vessels (Fig. 3I,J) which is associated
with endothelial cell activation and increased inflammatory cell
trafficking (Dietrich, 2002). Quantification of ICAM-1 expression
revealed that a significantly higher percentage of cerebral vessel
length expressed ICAM-1 in the PDGFrb-cre;Foxc1fl-fl mutants
than in control at E18.5 (Fig. 3K). Enlarged vessels and activated
microglia were seen as early as E15.5 and E16.5 in PDGFrb-
cre;Foxc1fl-fl mutant cortices (supplementary material Fig. S1).
We also observed small hemorrhages in the midbrain and
cerebellum of PDGFrb-cre;Foxc1fl-fl mutants at E18.5
(Fig. 3L–O), though the size and number of the micro-
hemorrhages was less frequent than in rostral brain structures.
We next used Zic-1 and PDGFrb immunolabeling along with
BrdU incorporation to determine whether pericyte density and
proliferation in the cerebral vasculature was altered in PDGFrb-
cre;Foxc1fl-fl mutants at E14.5. We chose to look at this
developmental stage because it is prior to observable hemorrhage
and vascular dysplasia. At E14.5, more Zic-1+ pericyte nuclei
were associated with cortical blood vessels in PDGFrb-
cre;Foxc1fl-fl mutants and many of these were also BrdU+
(Fig. 4A,C,E,F). Indeed, both pericyte proliferation and pericyte
nuclei per vessel length were significantly increased in PDGFrb-
cre;Foxc1fl-fl mutants compared to littermate controls at E14.5
Fig. 2. Altered brain pericyte proliferation in
Foxc1 mutants. (A–C) PDGFrb (green) and IB4
(red) immunofluorescence highlight pericyte cell
bodies in the cortices of E14.5 WT, Foxc1h/h and
Foxc1l/l. (D–F) Triple immunofluorescence for
Zic1 (pericyte nuclei; green), BrdU (red) and
IB4 (blue) highlight proliferating (Zic1+/BrdU+;
arrows) pericytes in the E14.5 cerebral
vasculature of WT, Foxc1h/h and Foxc1l/l
embryos. (G) Graph depicting quantification of
Zic1+ pericyte nuclei/vessel length in all three
genotypes at E14.5. (H) Graph depicting
quantification of pericyte proliferation (labeling
index) at E14.5. Scale bars: 100 mm. Means
represent analysis of three independent litters for
each mutant genotype (n53). Asterisks indicate
a statistically significance difference from WT
(P,0.05). Error bars depict 6SEM.
Foxc1 and brain pericytes 649
B
io
lo
g
y
O
p
e
n
(Fig. 4G,L). Even more pericytes covered cerebral vessels
in PDGFrb-cre;Foxc1fl-fl mutants at E18.5 (Fig. 4H,J)
demonstrated by a significant increase in pericyte nuclei per
vessel length from E14.5 to E18.5 in the mutants (Fig. 4L). This
progressive increase in pericyte number is likely due to
dysregulated pericyte proliferation in the absence of Foxc1. As
with Foxc1 mutants, PDGFrb immunolabeling did not reveal any
significant changes in vessel coverage by pericytes though,
consistent with Zic-1 anlysis, there were more pericyte cell
bodies in the PDGFrb-cre;Foxc1fl-fl mutants at both E14.5
(Fig. 4B,C) and E18.5 (Fig. 4I,K).
During the course of our analyses of the vascular phenotype in
PDGFrb-cre;Foxc1fl-fl mutant brain, we noted a moderate
lengthening of the cerebral neuroepithelium, first observed at
E15.5 and also present at E17.5 (supplementary material Fig.
S2A–D). This phenotype appeared to be a much milder version of
the cortical phenotype we previously described in Foxc1h/h and
Foxc1l/l mutants in which absence of the forebrain meninges and
meningeal-derived signals leads to defects in cortical neurogen-
esis (Siegenthaler et al., 2009). This, in conjunction with the
perinatal lethality of PDGFrb-cre; Foxc1fl-fl mutants, suggested
that PDGFrb-cre activity is not specific for the pericyte and
vSMC population and is active in other tissues that express
Foxc1. Examination of PDGFrb-cre recombinase activity using
the Rosa26-YFP reporter line revealed that cre activity was
limited to pericytes and vSMCs in the PNVP and in the head and
brain vasculature at E12.5 (supplementary material Fig. S2E–G),
but by E13.5 there was also recombination in the facial and
calvarial mesenchyme, and in a large portion of the meninges
(supplementary material Fig. S2H,I). Given that Foxc1 is critical
for development of the forebrain meninges (Siegenthaler et al.,
2009; Vivatbutsiri et al., 2008) we next determined whether the
meninges were affected by the later recombination of Foxc1
using Zic-1 immunolabeling. The number of Zic-1+ meningeal
Fig. 3. Vascular defects and brain micro-
hemorrhage in pericyte conditional Foxc1
mutants. (A) RT-PCR of Foxc1 transcript from
three RNA sources: (1) E18.5 PDGFrb-cre;
Foxc1fl-+ meninges (2) E18.5 microvessels
from PDGFrb-cre; Foxc1fl-+ brain and (3)
E18.5 microvessels from PDGFrb-cre; Foxc1fl-
fl brain. Housekeeping gene GAPDH serves as
internal control. (B) Whole embryo images of
E18.5 PDGFrb-cre; Foxc1fl-fl mutant and
PDGFrb-cre; Foxc1fl-+ littermate.
(C–E) Dorsal view of E18.5 PDGFrb-cre;
Foxc1fl-+ (C) and PDGFrb-cre; Foxc1fl-fl
mutant (D,E) brains. Arrows indicate
hemorrhage within the cerebral cortex.
(F,G) Glut-1 (green), Ib4 (red) and DAPI (blue)
stained cortical sections of E18.5 PDGFrb-cre;
Foxc1fl-fl mutant and PDGFrb-cre; Foxc1fl-+
animals. (H) Graphs depicting quantification of
average cerebral vessel diameter (top) and
cerebral vessel density (bottom) in E18.5
PDGFrb-cre; Foxc1fl-fl mutant and PDGFrb-
cre; Foxc1fl-+ animals. Means represent
analysis from three separate litters (n53).
(I,J) ICAM-1 and IB4 immunofluorescence of
E18.5 PDGFrb-cre; Foxc1fl-+ and PDGFrb-
cre; Foxc1fl-fl cortices. Arrowheads indicate
superficial ICAM-1+ cerebral vessels
descending from the perineural vascular plexus
(PNVP). Arrows indicate deeper, ICAM-1+
vessels in PDGFrb-cre; Foxc1fl-fl mutant
cortices. (K) Quantification of percentage of
ICAM+ cerebral vessels in control and mutant
samples analyzed from three independent litters
(n53). (L,M) Sagittal view of midbrain and
cerebellum of E18.5 PDGFrb-cre; Foxc1fl-fl
mutant and PDGFrb-cre; Foxc1fl-+ brains.
Arrows indicate hemorrhage sites in PDGFrb-
cre; Foxc1fl-fl sample. (N,O) Glut-1 (green), Ib4
(red), DAPI (blue) immunofluorescence at the
level of the midbrain (N) and cerebellum (O) in
E18.5 PDGFrb-cre; Foxc1fl-fl mutant brains. In
G,N,O, arrowheads indicate amoeboid
morphology of Ib4+ activated microglia; arrows
indicate dilated/dysplastic vessels; asterisks
indicate red blood cells in the neural
parenchyma. Scale bars: 100 mm. Asterisks in
graph indicate a statistically significant
difference from PDGFrb-cre; Foxc1fl-+
samples (P,0.05). Error bars depict 6SEM.
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cells was normal at E14.5 in PDGFrb-cre;Foxc1fl-fl mutants,
however, by E16.5 there was an obvious decrease in Zic-1+ cells
overlying the cortex (supplementary material Fig. S2J–M).
Presumably, this mid-corticogenesis decline in meningeal
coverage causes the cortical phenotype in PDGFrb-
cre;Foxc1fl-fl mutants, however, we do not believe that the
meningeal defects and mild cortical defects contribute to the
brain vascular phenotype in these mutants. This is supported by
the fact that meninges loss and mild cortical defects in PDGFrb-
cre;b-catenin-lof-lof mutants (Choe et al., 2012) are not
associated with cerebral vascular defects (supplementary
material Fig. S3).
Fig. 4. Pericyte conditional Foxc1 mutants have increased pericyte proliferation and density in the cerebral vasculature. (A,C) Zic1 (green) and IB4 (red)
co-immunofluorescence in the cortices of PDGFrb-cre; Foxc1fl-fl mutant and PDGFrb-cre; Foxc1fl-+ brains at E14.5. (B,D) PDGFrb (green) and IB4 (red)
co-immunofluorescence in the cortices of PDGFrb-cre; Foxc1fl-fl mutant and PDGFrb-cre; Foxc1fl-+ brains at E14.5. Arrowheads indicate PDGFrb+ pericytes.
(E,F) Zic1 (green), BrdU (red), and IB4 (blue) triple immunofluorescence of E14.5 PDGFrb-cre; Foxc1fl-fl mutant and PDGFrb-cre; Foxc1fl-+ cerebral cortex.
Arrows indicate Zic1+/BrdU+ pericytes. (G) Graph depicts quantification of Zic1+ pericyte proliferation (labeling index) in the cerebral vasculature at E14.5.
(H,J) Zic1 (green) and IB4 (red) co-immunofluorescence in the cortices of PDGFrb-cre; Foxc1fl-fl mutant and PDGFrb-cre; Foxc1fl-+ brains at E18.5.
(I,K) PDGFrb (green) and IB4 (red) co-immunofluorescence in the cortices of PDGFrb-cre; Foxc1fl-fl mutant and PDGFrb-cre; Foxc1fl-+ brains at E18.5.
Arrowheads indicate PDGFrb+ pericytes. (L) Graph depicts pericyte density (Zic1+ pericyte nuclei/vessel length) in the cerebral vasculature at E14.5 and E18.5 in
PDGFrb-cre; Foxc1fl-fl mutant and PDGFrb-cre; Foxc1fl-+ animals. Asterisks indicate a statistically significance difference from PDGFrb-cre; Foxc1fl-+ samples
(P,0.05). Analysis of pericyte proliferation and density was performed on control and mutant brains from three separate litters at each time point (n53). Error bars
depict 6SEM. Scale bars in A,C,E,F,H,J: 100 mm. Scale bars in B,D,I,K: 50 mm.
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Foxc1-deficient pericytes associate normally with hyperplastic
cerebral blood vessels
Alterations in pericyte association with CNS blood vessels
interfere with their ability to regulate vascular stability and BBB
permeability (Li et al., 2011). Thus we used electron microscopy
(EM) to evaluate pericyte–EC interactions in the cortices of
E18.5 PDGFrb-cre;Foxc1fl-fl mutants and littermate controls.
Pericytes were always close to the abluminal surface of ECs in
both control and PDGFrb-cre;Foxc1fl-fl mutants (Fig. 5F,G).
There was a small increase in the percentage of EC surface area
covered by pericyte cell bodies and processes (Fig. 5E) though it
was not statistically significant. This indicates that the increase in
Fig. 5. Ultrastructure analysis of pericyte–EC interactions reveals EC hyperplasia and increased EC cell proliferation in conditional Foxc1 mutants.
(A–D) High magnification image of contact points between EC and pericyte cell membranes highlight pericyte–EC interactions – ‘‘peg and socket’’ (A,B) and
adhesion plaques (arrows in C,D) in cerebral vessels of Foxc1fl-fl and PDGFrb-cre; Foxc1fl-fl mutant animals. (E) Graph depicting analysis of pericyte coverage of
abluminal surface of cerebral blood vessels in E18.5 control and mutant samples. (F,G) EM images of cerebral vessel cross-sections highlighting increased EC nuclei
and tight-juntions (red arrows) in PDGFrb-cre; Foxc1fl-fl mutant cortices. (H) Graph depicting quantification of tight junction density (left) and EC nuclei density
(right) from EM images of Foxc1fl-fl and PDGFrb-cre; Foxc1fl-fl mutant animals. (I,J) Triple immunofluoresence for Lef-1 (green: ECs), BrdU (red) and IB4 (blue)
in E16.5 PDGFrb-cre; Foxc1fl-+ and PDGFrb-cre; Foxc1fl-fl cortices. Arrows indicates Lef-1+/BrdU+ ECs. (K) Graph depicts quantification of Lef-1+ EC
proliferation (labeling index) in the cerebral vasculature at E16.5. PC: pericyte. EC: endothelial cell. TJ:tight junctions. Scale bars: 0.5 mm (A–D); 2 mm
(F,G); 100 mm (I,J). Asterisks indicate a statistically significance difference between control and mutant samples (P,0.05). EM analysis was performed on images
from three PDGFrb-cre; Foxc1fl-fl samples (n53) and two control Foxc1fl-fl samples (n52). EC proliferation analysis was performed on control and mutant brains
from two independent litters (n52). Error bars depict 6SEM.
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pericyte number does not result in abnormal distribution or
pericyte process overlap. Importantly, we observed cytoplasmic
interdigitation of pericytes and ECs (‘‘peg-and-socket’’ junctional
complexes) (Fig. 5A,B) and adhesion plaques (Fig. 5C,D) with
similar frequency in both control and PDGFrb-cre;Foxc1fl-fl
mutants. Collectively this evidence indicates that, despite the
increased numbers of pericytes, characteristic pericyte–EC
interactions are overtly normal in PDGFrb-cre;Foxc1fl-fl
mutants.
The EM analysis also highlighted a significant increase in the
number the EC nuclei in PDGFrb-cre;Foxc1fl-fl mutant cerebral
vessels, and subsequently, tight junctions connecting the
supernumerary ECs (Fig. 5F–H). These changes are consistent
with an increase in EC number within the cerebral blood vessels
and may underlie the increased vessel size observed in these
mutants. Pericytes are known to suppress EC cell proliferation in
vitro (Orlidge and D’Amore, 1987) thus EC hyperplasia in
PDGFrb-cre;Foxc1fl-fl mutants may be caused by increased EC
proliferation. To confirm this, we determined the proportion of
proliferating ECs in control and mutant vessels at E16.5 using
BrdU pulse labeling in conjunction with a nuclear marker of ECs,
Lef-1. Lef-1 is a Wnt-regulated transcription factor, and,
consistent with the role of Wnt signaling in the
neurovasculature (Daneman et al., 2009; Stenman et al., 2008),
it is expressed at high levels in all brain EC nuclei. Consistent
with our analysis of vessels at the EM level, Lef-1+ EC nuclei
were more numerous in PDGFrb-cre;Foxc1fl-fl mutant cerebral
vessels (Fig. 5I,J). Importantly, the proportion of BrdU+/Lef+
cells in mutant brains was significantly elevated (Fig. 5K),
indicating that EC proliferation is increased and likely the main
contributor to the hyperplastic vascular phenotype in these
mutants.
Limited BBB leakage in PDGFrb;Foxc1fl-fl mutants
Brain pericytes have long been thought to play roles in BBB
formation and maintenance (Dente et al., 2001; Dohgu et al.,
2005), however recent work showing severe defects in the
integrity of the BBB in pericyte-deficient mutants provides the
most compelling evidence to date (Armulik et al., 2010;
Daneman et al., 2010b). To examine the BBB in PDGFrb-
cre;Foxc1fl-fl mutants, we assessed cerebral vascular
permeability to large (70 kDa dextran) and small (3 kDa
dextran and cadaverine: ,1kDa) molecules at E18.5. PDGFrb-
cre;Foxc1fl-fl mutants did not display widespread permeability to
dextrans or cadaverine but had focal extravasation of tracers,
especially cadaverine (Fig. 6A,B) and 70 kDa dextran
(Fig. 6E,F) in the vicinity of hemorrhages. Larger sites of
tracer leakage were often accompanied by activated microglia
(Fig. 6B), supporting the idea that tracer leak is associated with
an active hemorrhage site. In other cases, extravasation of both
70 kDa dextran and cadaverine was limited to a small area
immediately adjacent to a single vessel (Fig. 6B,F). Other than
these areas of focal leakage, we did not detect significant
vascular permeability to 70 kDa or 3 kDa dextran (Fig. 6G) nor
was there widespread neuronal uptake of leaked cadaverine as
was described previously in pericyte-deficient mutants
(Fig. 6A,B) (Armulik et al., 2010).
Tracer extravasation was sometimes observed in small
diameter vessels (Fig. 6B,F), though it was more common to
observe tracer leakage in grossly enlarged vessels in PDGFrb-
cre;Foxc1fl-fl mutant brains (Fig. 6H). To quantify this, we
determined the average vessel diameter of vessels with no
leakage in control and mutant brains as well as the average vessel
diameter of vessels with extravasation of 70 kDa dextran in
mutant brains. There was a small but significant increase in
vessel diameter in mutants with no 70 kDa leakage as compared
to control (Fig. 6I). In contrast, the average vessel diameter of
vessels with 70 kDa extravasation was substantially larger than
no-leak vessels in either mutant or control (Fig. 6I). These data
suggest that increased vessel size, likely caused by elevated EC
proliferation, correlates with vessel instability.
Expression profiling of pericyte conditional Foxc1 mutant
microvessels
Microarray profiling of microvessels from pericyte-deficient
mutants has generated both a comprehensive list of genes
enriched in brain pericytes and revealed changes in endothelial
cell gene expression consistent with increased vascular instability
(Armulik et al., 2010; Bondjers et al., 2006; Daneman et al.,
2010a; Daneman et al., 2010b). Using these published microarray
data as well as the pericyte literature, we compiled a list of
relevant pericyte and endothelial cell expressed genes to examine
for changes in expression in microvessels isolated from pericyte
conditional Foxc1 mutants using quantitative real time-PCR.
Microvessels, which contain both ECs and pericytes, were
isolated from E18.5 control (PDGFrb-cre;Foxc1-fl/+ and
Foxc1fl/fl) and PDGFrb-cre;Foxc1fl/fl brains using PECAM-
coated magnetic beads (Fig. 7A). We confirmed that both cell
types were present by examining microvessels isolated from
PDGFrb-cre/+;Foxc1-fl/+;Rosa26-YFP/+ brains; recombined,
GFP+ pericytes were visibly associated with IB4+ blood vessels
(Fig. 7A).
We first looked at expression of endothelial cell enriched
genes, some of which were upregulated in pericyte-deficient
microvessels and thus may be involved in the vascular defects
observed in these mutants. Expression of endothelial cell-specific
genes CD144 (VE-Cadherin) and PDGFB were not significantly
altered in PDGFrb-cre;Foxc1fl/fl microvessels (Fig. 7B).
Further, genes previously shown to be upregulated in pericyte-
deficient brain microvessels and known to be involved in
vascular homeostasis (Angpt2, Edn1, Esm1, and Ptgs2) were
not significantly altered (Fig. 7B). However, two genes known to
be expressed by ECs, F2R and MMP-9, were significantly
upregulated in PDGFrb-cre;Foxc1fl/fl microvessels at both the
mRNA and protein levels (Fig. 7C,D). F2R, more commonly
known as PAR-1, is a thrombin receptor that mediates thrombin-
induced EC permeability after injury (Komarova et al., 2007).
PAR-1 is also expressed by platelets, which could be present at
greater numbers in pericyte conditional Foxc1 mutants due to
active hemorrhage sites, although we did not see increased
expression of the platelet marker CD41 (Fig. 7C). Since PAR-1 is
also expressed by vSMCs, and potentially pericytes, it is possible
this increase is due to expression in either ECs or vSMCs/
pericytes. MMP9, through degradation of the ECM, can alter
BBB permeability (Asahi et al., 2001) but is frequently increased
after brain ischemia. Consequently, the increase in MMP-9 may
be a result rather than the cause of the vascular leak.
Nevertheless, elevated MMP-9 levels could exacerbate the
existing vascular instability phenotype our mutants.
We next looked at expression of genes enriched in pericytes,
classified as such by decreased expression in brain microvessels
isolated from pericyte-deficient mice and expression analysis in
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situ (Armulik et al., 2010; Bondjers et al., 2006; Daneman et al.,
2010b). We found that several pericyte-enriched genes (PDGFrb,
Notch3, S1pr3, Intgb5, Cspg4, Gja7) were uniformly upregulated
1.6–1.7 fold compared to control (Fig. 7E), perhaps due to the
fact that more pericytes are associated with blood vessels in
pericyte conditional Foxc1 mutants rather than increased
expression on a cellular level. This is supported by the fact that
we do not see an appreciable increase in PDGFrb protein
expression in individual brain pericytes (Fig. 4I,K). Cell
proliferation defects in both pericytes and ECs point toward
cell cycle regulators like p21, p27, and cyclin D1 as well as
TGFb signaling, which has been previously implicated in
pericyte-mediated control of EC proliferation in vitro
(Antonelli-Orlidge et al., 1989). We did not, however, detect
significant changes in gene expression of these cell cycle
regulators, TGFb1 ligand or TGFb receptor 2.
Extracellular matrix (ECM) proteins and proteoglycans, either
membrane bound and within the ECM, contribute significantly to
the rich, extracellular environment that encases blood vessels and
pericytes. ECs and pericytes secrete the majority of the ECM
Fig. 6. BBB integrity in pericyte conditional Foxc1 mutants. (A,B) Foxc1fl-fl and PDGFrb-cre; Foxc1fl-fl mutants injected with fluorophore-linked cadaverine
tracer show strong labeling of bone and skin tissues where the tracer leaked out of fenestrated (non-barrier) vessels, but no significant leakage in brain tissue except
for adjacent to a hemorrhage site in the PDGFrb-cre; Foxc1fl-fl mutant brain (arrow). Magnified inset in (B) highlights tracer leak out of a vessel (arrow) and an
adjacent activated, IB4+ microglia with amoeboid morphology (arrowhead). (C–F) Representative images of biotin-conjugated 3kDa (C,D) and 70 kDa dextran
tracers (E,F) from E18.5 Foxc1fl-fl and PDGFrb-cre; Foxc1fl-fl mutants cortices. Note tracer signal trapped in choroid plexus (CP). In F, magnified inset is of
cerebral vessel with leakage of 70 kDa dextran tracer. (G) Graph depicts quantification of BBB permeability to 3 kDa and 70 kDa dextran tracers as measured by
fluorescent intensity of cerebral tissue relative to PBS control. (H,H9) Representative large diameter cerebral vessel (Ib4+, red) in PDGFrb-cre; Foxc1fl-fl mutant
brain displaying vascular leak of 70 kDa tracer (green). (I) Graph depicting mean cerebral vessel diameter of vessels without and with 70 kDa tracer extravasation in
control and mutant samples. Scale bars: 100 mm. Asterisks indicate a statistically significance difference from control samples (P,0.05). Analysis of BBB
permeability was performed on three control and three mutant brains (n53). Error bars depict 6SEM.
Foxc1 and brain pericytes 654
B
io
lo
g
y
O
p
e
n
Fig. 7. qPCR profiling of pericyte conditional Foxc1 mutant brain microvessels. (A) Schematic of microvessel isolation from E18.5 brain and both brightfield
(top) and fluorescence (bottom) image of microvessels following magnetic bead isolation. Arrow indicates recombined, GFP+ pericyte associated with IB4+
microvessel isolated from PDGFrb-Cre; Rosa26-YFP brain (B,C). Graphs depicting expression analysis of EC-expressed genes. (D) Immunoblots of Par1 and MMP9
on whole cortex lysate from E18.5 PDGFrb-cre; Foxc1fl-+ or Foxc1fl-fl (control or ‘‘C’’) and PDGFrb-cre; Foxc1fl-fl (mutant or ‘‘M’’). Graphs depict relative
intensity of the Par1 or MMP9 band to control samples. (E–I) Graphs depicting expression analysis of pericyte-enriched genes (E), cell cycle genes and TGFb
signaling components (F), pericyte-enriched ECM genes (G), and pericyte-enriched proteoglycans (H). (I) Immunoblots of glypican-3 and asporin on whole cortex
lysate from E18.5 PDGFrb-cre; Foxc1fl-+ or Foxc1fl-fl (control) and PDGFrb-cre; Foxc1fl-fl (mutant). Graphs depict relative intensity of the glypican-3 or asporin
band to control samples. Asterisks indicate a statistically significance difference from control samples (P,0.05). qPCR analysis was performed on RNA isolated from
six mutant (n56) and five control (n55) E18.5 brains. Immunoblot analysis was performed on lysates from three control and three mutant cortices (n53). Error bars
depict 6SEM.
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proteins that make up the vascular basement membrane. Loss
of ECM expression can significant affect brain vascular stability
(Gould et al., 2005; Gustafsson et al., 2013) thus we determined
whether ECM genes expressed by pericytes were altered in
microvessels from PDGFrb-cre;Foxc1fl/fl microvessels. A
collagen subtype (Col3a) and a laminin subtype (Lama2) were
significantly increased, though overall there were no major
changes in laminin, collagen and vitronectin gene expression
(Fig. 7G). Also, continuity of laminin and a collagen subtype,
Col4a, protein expression along the vessel surface was not
altered between control and mutant samples at E18.5
(supplementary material Fig. S4), indicating that ECM deposition
and organization is not significantly affected. Collectively this
suggests that the ECM-enriched vascular basement membrane is
intact in PDGFrb-cre;Foxc1fl/fl mutant brains. We did, however,
identify two pericyte-expressed proteoglycans that showed
notable changes in expression in the pericyte conditional Foxc1
mutants. Glypican-3 expression was downregulated 2-fold
whereas Asporin was upregulated 4-fold in mutant microvessels
(Fig. 7H). Changes in asporin and glypican-3 protein expression
were verified at the protein level using immunoblots of whole
brain lysates (Fig. 7I). Glypican-3, and to a lesser extent asporin,
have established roles in modulating growth factor signaling
pathways like TGFb, Wnt, Sonic Hedgehog (Shh), BMP and FGF
in part by sequestering ligands away from or chaperoning ligands
to their cell surface receptors (Capurro et al., 2005; Capurro et al.,
2008; Hartwig et al., 2005; Ikegawa, 2008; Stigliano et al., 2009).
Altered composition of these pericyte-expressed proteoglycans in
the absence of Foxc1 may alter growth factor signaling at the cell
surface and, in this way, negatively impact pericyte and EC
proliferation.
Discussion
In this study we identified Foxc1 as a critical transcription factor
regulating multiple aspects of pericyte function in the developing
brain. Foxc1 is expressed by brain pericytes and vSMCs during
development and late gestation pericyte-conditional Foxc1
mutants display dysplastic vessels and micro-hemorrhages,
most prominently in the cerebral cortex.
We believe that one of the key phenotypes in pericyte
conditional Foxc1 mutants is the increase in both pericyte and EC
proliferation. For pericytes, this equates to a small (,2 vs. ,3
pericyte/100 mm vessel) but significant increase in pericyte
number. Despite the increase in number, Foxc1-deficient
pericytes associate normally with ECs and display overtly
normal coverage of the vessel surface. This is an important
observation in light of recent work showing that the brain
hemorrhage and BBB defects in a cerebrovascular-specific
knockdown of Smad4 are accompanied by pericyte detachment
(Li et al., 2011). For ECs, it is unlikely that the increase in cell
proliferation reflects an increase in angiogenic growth in the
mutant vasculature, in large part because there is no observed
increase in vessel density in pericyte conditional Foxc1 mutants.
Rather, we suspect that in the absence of the correct signal from
the pericytes, there is a failure in EC quiescence that normally
accompanies vessel maturation and stability. Ectopic cell division
within a capillary likely causes an uneven increase in diameter
along the vessel length, crowding of endothelial cell bodies and,
potentially, destabilization of junctional contacts that must
reorganize to incorporate the newly born cell. These structural
changes may leave vessels vulnerable to the shear stress forces of
blood flow and are likely a major causal factor for the micro-
hemorrhages in our mutants. Indeed, vascular leak indicative of
weak cell–cell contacts was most frequently observed in
abnormally large diameter blood vessels in the conditional
Foxc1 mutants.
One major question is how Foxc1, when deleted in only
pericytes and vSMCs using the PDGFrb-Cre, can regulate cell
proliferation in both pericytes and ECs. On the one hand, Foxc1
may directly regulate expression of genes involved in pericyte
proliferation. Foxc1, downstream of TGFb signaling, is important
for growth suppression in several human cancer cell lines (Zhou
et al., 2002), however, there is growing evidence that high
expression of Foxc1 is correlated with increased breast cancer
growth (Wang et al., 2012). Also, we observed no changes in
TGFb1 ligand expression or in expression of TGFbr2, the key
signaling receptor for TGFb ligands. Further, important cell cycle
regulators were also unchanged in pericyte conditional Foxc1
mutants. With no firmly established role for Foxc1 in regulating
cell proliferation, one intriguing possibility comes from profiling
data on microvessels isolated from pericyte conditional Foxc1
mutants where we observed altered expression of pericyte-
expressed proteoglycans asporin and glypican-3. Asporin is the
predominant, non-collagen extracellular matrix protein in
cartilage where it has been shown to bind to and block TGFb1-
activated signaling in chondrocytes (Nakajima et al., 2007).
Glypican-3 is a heparin sulfate proteoglycan that is widely
expressed in embryonic tissues where it has been shown to
modulate several signaling pathways, including Sonic hedgehog,
FGF and Wnt (Fico et al., 2011). Glypican-3 is membrane bound
with a large extracellular domain that can interact with either the
surface-bound receptors or ligands to modulate signaling
‘‘strength’’ either positively or negatively. The collective effect
of glypican-3 on these pathways translates into growth inhibition.
The extracellular space between the surface of a pericyte and EC
is narrow and proteoglycans secreted by (e.g. asporin) or bound
to the surface (e.g. glypican-3) of pericytes can potentially affect
receptor-mediated signaling occurring at the surface of both cell
types. Thus in the absence of Foxc1, brain pericytes fail to
express appropriate levels of proteoglycans like asporin and
glypican-3 and, in this way, may disrupt normal cell surface
regulation of signaling pathways involved in cell proliferation.
Pericyte-conditional Foxc1 mutants have similar phenotypic
features as pericyte-deficient mutants, including large-diameter,
hyperplastic cerebral vessels and vascular instability (Lindahl et
al., 1997; Hellstro¨m et al., 2001). Unlike pericyte deficient
mutants (Armulik et al., 2010; Daneman et al., 2010b), pericyte
conditional Foxc1 mutants do not display systemic permeability
to large and small molecular weight tracers in the fetal brain. This
suggests Foxc1 is not involved in pericyte-mediated BBB
formation. Importantly, we did not observe evidence of
increased endothelial trancytosis at the EM level, which is the
probable mechanism underlying the increased BBB permeability
in the pericyte-deficient mutants. Further, two genes implicated
in pericyte-induced barriergenesis, angiopoietin-1 and
angiopoietin-2, are not significantly altered in our mutants.
Pericyte–EC direct contact, which is intact in pericyte conditional
Foxc1 mutants, is also likely important for the ability of pericytes
to limit BBB permeability. Indeed, pericyte–EC co-cultures in
which the two cells types are in contact displayed a greater
decrease in vascular permeability than non-contact co-cultures
(Dohgu et al., 2005).
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The late-gestation brain vascular defects and micro-
hemorrhages in pericyte conditional Foxc1 mutants are much
milder that the severe cerebral hemorrhage observed in Foxc1-
null mutant embryos at the same developmental stage (Kume et
al., 1998). Though Foxc1 is expressed by brain ECs, severe
vascular defects are not seen in EC-conditional Foxc1 mutants
(Hayashi and Kume, 2008). This suggests a non-cell autonomous
contribution to the vascular phenotype in Foxc1 mutant mice.
Neocortical development is disrupted in Foxc1 mutant mice due
to increased self-renewing divisions by neural progenitors at the
expense of neuron production (Siegenthaler et al., 2009). The
result is a long, thin neocortex. Critical neuroangiogenic
molecules like VEGF and Wnt ligands are produced, to varying
degrees, by neural progenitors and post-mitotic neurons within
the developing brain (Breier et al., 1992; Stenman et al., 2008).
Thus the neural tissue likely creates angiogenic gradients that
blood vessels use to properly grow within the developing brain.
The disrupted forebrain architecture of Foxc1 mutant mice may
disturb the formation of these gradients, thus negatively
impacting vascular growth. Retinoic acid, normally produced
by the meninges but lacking in meninges-deficient Foxc1
mutants, improves many of the neocortical defects in Foxc1
mutant mice (Siegenthaler et al., 2009). In later gestation, non-
retinoic acid exposed Foxc1 mutant mice display severe cerebral
hemorrhage whereas retinoic acid treated embryos do not,
suggesting that the rescue of neocortical defects may also
improve vascular development (J.A.S. and S.J.P., unpublished
observations). Further analysis comparing retinoic acid rescued
Foxc1 mutants and pericyte conditional Foxc1 mutants could
prove useful is determining the relative contribution of pericyte
dysfunction and defects in neocortical development to the
vascular defects in Foxc1-null mice.
Recent work on CNS pericytes has revealed an important role
for these cells in various CNS disease states, including as BBB
gatekeepers warding off neurodegeneration (Bell et al., 2010;
Bell et al., 2012) and as major participants in the formation in the
fibrotic scar following spinal cord and stroke-induced brain
injury (Go¨ritz et al., 2011; Ferna´ndez-Klett et al., 2013). Given
the variety of pericyte activities in the brain endothelium,
dissecting how pericytes function in different capacities becomes
somewhat problematic. The utility of the pericyte conditional
Foxc1 mutants is that the brain pericytes are present and
functioning normally in some capacities (e.g. BBB permeability)
but fail in others (e.g. vascular morphogenesis and stability).
Thus, in conjunction with existing and future work on the
pericyte deficient mutants, we hope to use pericyte conditional
Foxc1 mutants to connect pericyte-derived signals or properties
with specific effects on the brain vasculature. Identifying the
means by which pericytes ensure brain vascular integrity may
provide new therapies for treating CNS diseases that involve
vascular instability and disruption of the BBB.
Materials and Methods
Animals
Generation and genotyping of Foxc1-null and Foxc1-hith mice has been described
previously (Zarbalis et al., 2007; Siegenthaler et al., 2009). Foxc1-flox mice were
generated by T. Kume (Sasman et al., 2012) and genotyped using the following
primers: 59-ATTTTTTTTCCCCCTACAGCG-39 and 59-ATCTGTTAGTATCTC-
CGGGTA-39. PDGFrb-cre mice were generated by Ralf Adams at Cancer
Research UK (Foo et al., 2006) and generously provided by Calvin Kuo (Stanford
University). PDGFrb-cre mice were maintained as heterozygotes and breeders or
embryos were genotyped for the presence of the transgenic allele using standard
cre primers. Rosa26-YFP mice were obtained from Jackson Laboratories (Bar
Harbor, ME). To obtain mutant embryos, timed-matings were set up in the
afternoon and females were examined for a vaginal plug the following morning.
The day the plug was observed was counted as embryonic day (E) 0.5. All mice
were housed in specific-pathogen-free facilities approved by AALAC and were
handled in accordance with protocols approved by the UCSF Committee on
Animal Research.
Immunohistochemistry
Embryos (E12.5–E16.5) were collected and whole heads (E12.5–E14.5) or whole
brains (#E15.5) were fixed overnight in 4% paraformaldehyde. For E18.5, whole
heads were fixed as described above or a transcardiac perfusion was performed
with 3 ml PBS followed by 3 ml 4% paraformaldehyde. All tissues were
cryoprotected with increasing sucrose concentrations and frozen in OCT. Tissue
was cryosectioned in 12 mm increments. Immunohistochemistry was performed on
tissue sections as previously described (Zarbalis et al., 2007) using the following
antibodies: rabbit anti-Glut-1 1:500 (NeoMarkers/Thermo Scientific); mouse anti-
BrdU 1:50 (BDBioscience); rabbit anti-Zic1 1:100 (Novus Biologicals); goat anti-
Foxc1 1:300 (Novus Biologicals); goat anti-Foxc2 1:300 (Novus Biologicals);
rabbit anti-PECAM 1:200 (NeoMarkers/Thermo Scientific); rabbit anti-Fli1 1:200
(NeoMarkers/Thermo Scientific); rabbit anti-Lef-1 1:100 (Cell Signaling
Technology); mouse anti-SMAa 1:100 (Sigma-Aldrich); rabbit anti-PDGFrb
1:200 (Cell Signaling Technology); rat anti-ICAM-1 1:200 (Abcam); chicken anti-
GFP 1:500 (Invitrogen); rat anti-PDGFra 1:200 (BDBioscience); rabbit anti-
laminin 1:100 (Sigma). Following incubation with primary antibodies, sections
were incubated with appropriate Alexafluor-conjugated secondary antibodies
(Invitrogen), Alexafluor 633-conjugated isolectin-B4 (Invitrogen), and DAPI
(Invitrogen). For Zic1, Lef-1, Foxc1, and Foxc2 antibodies, immunostaining was
performed using the Tyramide System Amplification (TSA) Kit (Invitrogen) per
manufacturer’s instructions. All immunofluorescent and brightfield images were
captured using a Retiga CCD-cooled camera and associated QCapture Pro software
(QImaging Surrey, BC Canada).
Electron microscopy and ultrastructure analysis
E18.5 PDGFrb-cre; Foxc1fl-fl (n53) and Foxc1fl-fl littermate controls (n52)
were perfused with 4% paraformaldehyde, embedded in Histogel (Thermo
Scientific) and 400 mm vibrotome sections were generated. The thick sections
were put in Karnovsky’s fixative (1% paraformaldehyde/3% glutaraldehyde/0.1 M
sodium cacodylate buffer, pH 7.4) at 4 C˚ overnight. Fixed tissue was then rinsed in
water, post-fixed in reduced OsO4 (2% OsO4 + 1.5% potassium ferrocyanide,
Sigma, prepared fresh) and stained en bloc with uranyl acetate before being
dehydrated in ethanol, cleared in propyline oxide, and embedded in Eponate 12
(Ted Pella Co.). Thick sections were cut and stained with toludine blue then
examined under a light microscope to select the area to be thin sectioned. Thin
sections were cut by Leica Ultracut UCT microtome (Bannockburn, Il) and
visualized using a Philips Tecnai 10 electron microscope (Eidhoven, Netherland).
Images of cerebral blood vessels were captured with a SIA-L9C digital camera
(Duluth, GA). For quantitative analysis, EC nuclei number, tight junction number,
pericyte cell body/process length, and EC surface length were quantified using
ImageJ software (NIH) on a minimum of six images of cerebral blood vessels per
sample. To determine EC nuclei or tight junction number density, the EC nuclei or
tight junction number was divided by the EC surface dimension as measured in
microns. The percent coverage of EC surface by pericyte cell bodies was
calculated by dividing the sum cell body/process length by the EC surface
dimension.
Pericyte and EC cell proliferation
To quantify Zic1+ pericyte nuclei density in the cortex at E14.5 and E18.5, the
total number of Zic1+ nuclei was divided by the sum IB4+ vessel length in a 206
field. To determine pericyte cell proliferation at E14.5 and endothelial cell
proliferation at E16.5, pregnant dams were injected with BrdU (50 mg/kg body
weight) 2 hours prior to embryo collection. A pericyte labeling index was
calculated by dividing the total number of BrdU+/Zic1+ pericytes by the total
number of Zic1+ pericytes in a 206 field. All length measurements were
performed using ImageJ software (NIH) on a minimum of 5, 206 fields per brain.
For each genotype and age, the number of Zic1+ nuclei per vessel length and
pericyte labeling index was calculated from samples collected from three separate
litters (n53). Endothelial cell labeling index was quantified in the same manner
except Lef-1 was used to label all ECs. The endothelial cell labeling index was
calculated from control and mutant samples collected from 2 separate litters
(n52).
Quantitative analysis of vessel density/diameter and ICAM-1
expression
For all measurements, analysis was performed on E18.5 PDGFrb-cre; Foxc1fl-fl
mutants and littermate PDGFrb-cre; Foxc1fl-+ animals from three separate litters
(n53). To determine mean vessel density, the sum length of IB4+ cerebral vessels
was determined from a single 206 field. To determine mean vessel diameter, the
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average width of ,20 IB4+ cerebral vessels per 206 field was calculated. To
calculate the percentage of ICAM-1 expressing vessels, the sum length of ICAM-
1+ vessels was divided by the sum length of IB4+ vessels (total vessel length) in a
206 field. All length, diameter and ICAM-1 measurements were performed using
ImageJ software (NIH) on a minimum of five 206 fields per brain.
BBB permeability
E18.5 PDGFrb-cre; Foxc1fl-fl mutants and littermate controls (PDGFrb; Fox1fl-+
or Foxc1fl-fl) underwent transcardiac perfusion of Alexafluor-conjugated 555
cadaverine (200 ml of 0.25 mg/ml PBS; Invitrogen), biotin-conjugated 3 kD
dextran, lysine fixable (3 ml of 0.15 mg/ml PBS; Invitrogen), or 70 kDa dextran,
lysine fixable (3 ml of 3.5 mg/ml PBS; Invitrogen) followed immediately by 5 ml,
4% paraformaldehyde. Perfusions were performed by hand under a dissecting
scope using 30K gauge needles and a 1 or 5 ml syringe; care was taken to ensure
that solutions were delivered at approximately the same rate for all animals.
Following overnight fixation in 4% paraformaldehyde at 4 C˚, heads were
processed through sucrose solutions and cryosectioned at 20 mm thickness. For
animals injected for biotin-conjugate tracers, sections were washed in PBS then
incubated in Alexafluor 488 streptaviden (1:500; Invitrogen) for 1 hour at room
temperature. All sections were labeled with Alexafluor 633-conjugated isolectin-
B4 (Invitrogen) to visualize blood vessels. For 3 kDa and 70 kDa tracers,
fluorescent intensity in cortical tissue sections was determined using ImageJ
software; images from PDGFrb; Foxc1fl-fl mutants in which active hemorrhage
was observed were not used in the quantitative analysis. Average fluorescent
intensity of cerebral tissue for each animal was normalized to the fluorescent
intensity of cerebral tissue sections from an animal perfused with 3 ml PBS
followed by 5 ml 4% paraformaldehyde. For each tracer, a minimum of three
mutants and three controls were used for qualitative (cadaverine) or quantitative
(3 kDa and 70 kDa tracers) analysis (n53).
Immunoblots
Cortices of E18.5 PDGFrb-cre; Foxc1fl-fl mutants and littermate controls
(PDGFrb-cre; Foxc1fl-+, Foxc1fl-fl or Foxc1fl-+) from three separate litters
(n53) were collected, lysed in RIPA buffer (Sigma–Aldrich) containing a protease
inhibitor cocktail (Roche) and homogenized via sonication. Protein concentration
for each sample lysate was determined using a Nanodrop and associated software
(ThermoScientific). Lysates were combined with 46sample buffer (300 mM Tris,
5% SDS, 50% glycerol, 0.025% bromophenol blue, 250 mM b-mercaptoethanol),
run on Protean Tris-HCI 4–20% gradient gel (Bio-Rad) along with a Rainbow
molecular weight standard (Amersham/GE), and transferred onto PVDF
membranes (Bio-Rad). Immunoblots were blocked with 5% non-fat dehydrated
milk (NFDM) for 1.5 hour then incubated overnight at 4 C˚ in 2.5% NFDM
containing one of the following primary antibodies: rat anti-glypican-3 (Novus),
mouse anti-Par1 (BD Bioscience), goat anti-asporin (Novus), goat anti-MMP9
(R&D Systems). Following primary incubation, blots were washed then incubated
in the 2.5% NFDM containing the appropriate horseradish peroxidase-linked
secondary (1:5,000; Santa Cruz Biotechnology) for 45 min at room temperature.
Clarity ECL substrate (Bio-Rad) and the ChemiDoc MP system (Bio-Rad) were
used to visualize immunotagged protein bands. Densitometry of bands was
performed using ImageLab software (Bio-Rad); density values were corrected for
loading variations within each blot using the amount of b-actin expression.
Microvessel isolation and multi-gene transcriptional profiling
For isolation of microvessels, E18.5 brains were dissected out, meninges removed
and the forebrain region (cerebral cortex and striatum) was isolated in Hank’s
buffered salt solution (HBSS) and minced using a sharp forceps. Tissue was then
incubated for 15 min at 37 C˚ in HBSS containing 1% bovine serum albumin
(BSA), 5 mg/ml Collegenase A, 10 mg/ml Dnase 1, and 5 mg/ml glucose.
Following gentle pipetting to break up the tissue, the tissue suspension was passed
through a 100 mm filter, pelleted via centrifugation (1,000 RPM for 5 min) then
resuspended in HBSS containing 1% BSA. Cell suspension was then incubated
with rat anti-PECAM-conjugated dynabeads (BD Bioscience) for 45 min at 4 C˚.
Beads were collected using a magnetic particle concentrator followed by several
washes with 1% BSA in HBSS. RNA was collected from bead-bound microvessels
using the RNeasy Mini Kit (Qiagen). For expression of Foxc1 transcript using RT-
PCR, cDNA was generated from 100 ng of RNA using SuperScriptH VILOTM
cDNA Synthesis Kit (Invitrogen). For all other genes, multi-gene transcriptional
profiling, a form of quantitative RT-PCR, was used to determine the number of
mRNA copies per cell normalized to 18S rRNA abundance (106 18S-rRNA copies/
cell) (Shih and Smith, 2005) (see supplementary material Table S1 for primer
sequences). Multi-gene transcriptional profiling analysis was performed on
microvessels isolated from 5 control (PDGFrb-cre; Foxc1fl/+ or Foxc1fl/fl:
n55) and 6 (n56) mutant E18.5 brains.
Statistics
For pairwise analysis of control and mutant genotypes, Student t-tests were used.
The standard error of the mean (SEM) is reported on all graphs.
Acknowledgements
The authors would like to thank Trung Huynh and Jiasheng Zhang
for their technical expertise. J.A.S. would like to acknowledge the
contributions of Mack Lancaster and Alice Siegenthaler. This work
was supported by the following funding agencies: National Institutes
of Health/National Institute on Drug Abuse [R01 DA017627 to
S.J.P.], National Institutes of Health/National Institute of
Neurological Disorders and Stroke [K99-R00 NS070920 to J.A.S.],
American Health Association/American Academy of Neurology
[Lawrence M. Brass, M.D. Stroke Research Postdoctoral Fellowship
to J.A.S.], and VA Merit Review Award [BX0011-8 to E.J.H.] and
the Department of Defense Center for Neuroscience Excellence at
SFVAMC [to E.J.H.].
Competing Interests
The authors have no competing interests to declare.
References
Aldinger, K. A., Lehmann, O. J., Hudgins, L., Chizhikov, V. V., Bassuk, A. G.,
Ades, L. C., Krantz, I. D., Dobyns, W. B. and Millen, K. J. (2009). FOXC1 is
required for normal cerebellar development and is a major contributor to chromosome
6p25.3 Dandy-Walker malformation. Nat. Genet. 41, 1037-1042.
Antonelli-Orlidge, A., Saunders, K. B., Smith, S. R. and D’Amore, P. A. (1989). An
activated form of transforming growth factor beta is produced by cocultures of
endothelial cells and pericytes. Proc. Natl. Acad. Sci. USA 86, 4544-4548.
Armulik, A., Genove´, G., Ma¨e, M., Nisancioglu, M. H., Wallgard, E., Niaudet, C.,
He, L., Norlin, J., Lindblom, P., Strittmatter, K. et al. (2010). Pericytes regulate
the blood-brain barrier. Nature 468, 557-561.
Armulik, A., Genove´, G. and Betsholtz, C. (2011). Pericytes: developmental,
physiological, and pathological perspectives, problems, and promises. Dev. Cell 21,
193-215.
Asahi, M., Wang, X., Mori, T., Sumii, T., Jung, J. C., Moskowitz, M. A., Fini, M. E.
and Lo, E. H. (2001). Effects of matrix metalloproteinase-9 gene knock-out on the
proteolysis of blood-brain barrier and white matter components after cerebral
ischemia. J. Neurosci. 21, 7724-7732.
Bell, R. D., Winkler, E. A., Sagare, A. P., Singh, I., LaRue, B., Deane, R. and
Zlokovic, B. V. (2010). Pericytes control key neurovascular functions and neuronal
phenotype in the adult brain and during brain aging. Neuron 68, 409-427.
Bell, R. D., Winkler, E. A., Singh, I., Sagare, A. P., Deane, R., Wu, Z., Holtzman,
D. M., Betsholtz, C., Armulik, A., Sallstrom, J. et al. (2012). Apolipoprotein E
controls cerebrovascular integrity via cyclophilin A. Nature 485, 512-516.
Bergers, G. and Song, S. (2005). The role of pericytes in blood-vessel formation and
maintenance. Neuro-oncol. 7, 452-464.
Bjarnega˚rd, M., Enge, M., Norlin, J., Gustafsdottir, S., Fredriksson, S., Abramsson,
A., Takemoto, M., Gustafsson, E., Fa¨ssler, R. and Betsholtz, C. (2004).
Endothelium-specific ablation of PDGFB leads to pericyte loss and glomerular,
cardiac and placental abnormalities. Development 131, 1847-1857.
Bondjers, C., He, L., Takemoto, M., Norlin, J., Asker, N., Hellstro¨m, M., Lindahl,
P. and Betsholtz, C. (2006). Microarray analysis of blood microvessels from PDGF-
B and PDGF-Rbeta mutant mice identifies novel markers for brain pericytes. FASEB
J. 20, 1703-1705.
Breier, G., Albrecht, U., Sterrer, S. and Risau, W. (1992). Expression of vascular
endothelial growth factor during embryonic angiogenesis and endothelial cell
differentiation. Development 114, 521-532.
Capurro, M. I., Xiang, Y. Y., Lobe, C. and Filmus, J. (2005). Glypican-3 promotes the
growth of hepatocellular carcinoma by stimulating canonical Wnt signaling. Cancer
Res. 65, 6245-6254.
Capurro, M. I., Xu, P., Shi, W., Li, F., Jia, A. and Filmus, J. (2008). Glypican-3
inhibits Hedgehog signaling during development by competing with patched for
Hedgehog binding. Dev. Cell 14, 700-711.
Choe, Y., Siegenthaler, J. A. and Pleasure, S. J. (2012). A cascade of morphogenic
signaling initiated by the meninges controls corpus callosum formation. Neuron 73,
698-712.
Daneman, R., Agalliu, D., Zhou, L., Kuhnert, F., Kuo, C. J. and Barres, B. A.
(2009). Wnt/beta-catenin signaling is required for CNS, but not non-CNS,
angiogenesis. Proc. Natl. Acad. Sci. USA 106, 641-646.
Daneman, R., Zhou, L., Agalliu, D., Cahoy, J. D., Kaushal, A. and Barres, B. A.
(2010a). The mouse blood-brain barrier transcriptome: a new resource for
understanding the development and function of brain endothelial cells. PLoS ONE
5, e13741.
Daneman, R., Zhou, L., Kebede, A. A. and Barres, B. A. (2010b). Pericytes are
required for blood-brain barrier integrity during embryogenesis. Nature 468, 562-566.
Darland, D. C., Massingham, L. J., Smith, S. R., Piek, E., Saint-Geniez, M. and
D’Amore, P. A. (2003). Pericyte production of cell-associated VEGF is differentia-
tion-dependent and is associated with endothelial survival. Dev. Biol. 264, 275-288.
De Val, S., Chi, N. C., Meadows, S. M., Minovitsky, S., Anderson, J. P., Harris, I. S.,
Ehlers, M. L., Agarwal, P., Visel, A., Xu, S. M. et al. (2008). Combinatorial
Foxc1 and brain pericytes 658
B
io
lo
g
y
O
p
e
n
regulation of endothelial gene expression by ets and forkhead transcription factors.
Cell 135, 1053-1064.
Dente, C. J., Steffes, C. P., Speyer, C. and Tyburski, J. G. (2001). Pericytes augment
the capillary barrier in in vitro cocultures. J. Surg. Res. 97, 85-91.
Dietrich, J. B. (2002). The adhesion molecule ICAM-1 and its regulation in relation
with the blood-brain barrier. J. Neuroimmunol. 128, 58-68.
Dohgu, S., Takata, F., Yamauchi, A., Nakagawa, S., Egawa, T., Naito, M., Tsuruo,
T., Sawada, Y., Niwa, M. and Kataoka, Y. (2005). Brain pericytes contribute to the
induction and up-regulation of blood-brain barrier functions through transforming
growth factor-beta production. Brain Res. 1038, 208-215.
Etchevers, H. C., Vincent, C., Le Douarin, N. M. and Couly, G. F. (2001). The
cephalic neural crest provides pericytes and smooth muscle cells to all blood vessels
of the face and forebrain. Development 128, 1059-1068.
Ferna´ndez-Klett, F., Potas, J. R., Hilpert, D., Blazej, K., Radke, J., Huck, J., Engel,
O., Stenzel, W., Genove´, G. and Priller, J. (2013). Early loss of pericytes and
perivascular stromal cell-induced scar formation after stroke. J. Cereb. Blood Flow
Metab. 33, 428-439.
Fico, A., Maina, F. and Dono, R. (2011). Fine-tuning of cell signaling by glypicans.
Cell. Mol. Life Sci. 68, 923-929.
Foo, S. S., Turner, C. J., Adams, S., Compagni, A., Aubyn, D., Kogata, N.,
Lindblom, P., Shani, M., Zicha, D. and Adams, R. H. (2006). Ephrin-B2 controls
cell motility and adhesion during blood-vessel-wall assembly. Cell 124, 161-173.
Gaengel, K., Genove´, G., Armulik, A. and Betsholtz, C. (2009). Endothelial-mural
cell signaling in vascular development and angiogenesis. Arterioscler. Thromb. Vasc.
Biol. 29, 630-638.
Go¨ritz, C., Dias, D. O., Tomilin, N., Barbacid, M., Shupliakov, O. and Frise´n,
J. (2011). A pericyte origin of spinal cord scar tissue. Science 333, 238-242.
Gould, D. B., Phalan, F. C., Breedveld, G. J., van Mil, S. E., Smith, R. S., Schimenti,
J. C., Aguglia, U., van der Knaap, M. S., Heutink, P. and John, S. W. (2005).
Mutations in Col4a1 cause perinatal cerebral hemorrhage and porencephaly. Science
308, 1167-1171.
Gru¨neberg, H. (1943). Congenital hydrocephalus in the mouse, a case of spurious
pleiotropism. J. Genet. 45, 1-21.
Gustafsson, E., Almonte-Becerril, M., Bloch, W. and Costell, M. (2013). Perlecan
maintains microvessel integrity in vivo and modulates their formation in vitro. PLoS
ONE 8, e53715.
Hartwig, S., Hu, M. C., Cella, C., Piscione, T., Filmus, J. and Rosenblum, N. D.
(2005). Glypican-3 modulates inhibitory Bmp2-Smad signaling to control renal
development in vivo. Mech. Dev. 122, 928-938.
Hayashi, H. and Kume, T. (2008). Forkhead transcription factors regulate expression of
the chemokine receptor CXCR4 in endothelial cells and CXCL12-induced cell
migration. Biochem. Biophys. Res. Commun. 367, 584-589.
Hellstro¨m, M., Gerhardt, H., Kale´n, M., Li, X., Eriksson, U., Wolburg, H. and
Betsholtz, C. (2001). Lack of pericytes leads to endothelial hyperplasia and abnormal
vascular morphogenesis. J. Cell Biol. 153, 543-553.
Ikegawa, S. (2008). Expression, regulation and function of asporin, a susceptibility gene
in common bone and joint diseases. Curr. Med. Chem. 15, 724-728.
Inoue, T., Ogawa, M., Mikoshiba, K. and Aruga, J. (2008). Zic deficiency in the
cortical marginal zone and meninges results in cortical lamination defects resembling
those in type II lissencephaly. J. Neurosci. 28, 4712-4725.
Komarova, Y. A., Mehta, D. and Malik, A. B. (2007). Dual regulation of endothelial
junctional permeability. Sci. STKE 2007, re8.
Kume, T., Deng, K. Y., Winfrey, V., Gould, D. B., Walter, M. A. and Hogan, B. L.
(1998). The forkhead/winged helix gene Mf1 is disrupted in the pleiotropic mouse
mutation congenital hydrocephalus. Cell 93, 985-996.
Kume, T., Deng, K. and Hogan, B. L. (2000). Murine forkhead/winged helix genes
Foxc1 (Mf1) and Foxc2 (Mfh1) are required for the early organogenesis of the kidney
and urinary tract. Development 127, 1387-1395.
Kume, T., Jiang, H., Topczewska, J. M. and Hogan, B. L. (2001). The murine winged
helix transcription factors, Foxc1 and Foxc2, are both required for cardiovascular
development and somitogenesis. Genes Dev. 15, 2470-2482.
Li, F., Lan, Y., Wang, Y., Wang, J., Yang, G., Meng, F., Han, H., Meng, A., Wang,
Y. and Yang, X. (2011). Endothelial Smad4 maintains cerebrovascular integrity by
activating N-cadherin through cooperation with Notch. Dev. Cell 20, 291-302.
Lindahl, P., Johansson, B. R., Leve´en, P. and Betsholtz, C. (1997). Pericyte loss and
microaneurysm formation in PDGF-B-deficient mice. Science 277, 242-245.
Nakajima, M., Kizawa, H., Saitoh, M., Kou, I., Miyazono, K. and Ikegawa,
S. (2007). Mechanisms for asporin function and regulation in articular cartilage.
J. Biol. Chem. 282, 32185-32192.
Orlidge, A. and D’Amore, P. A. (1987). Inhibition of capillary endothelial cell growth
by pericytes and smooth muscle cells. J. Cell Biol. 105, 1455-1462.
Sasman, A., Nassano-Miller, C., Shim, K. S., Koo, H. Y., Liu, T., Schultz, K. M.,
Millay, M., Nanano, A., Kang, M., Suzuki, T. et al. (2012). Generation of
conditional alleles for Foxc1 and Foxc2 in mice. Genesis 50, 766-774.
Seo, S., Fujita, H., Nakano, A., Kang, M., Duarte, A. and Kume, T. (2006). The
forkhead transcription factors, Foxc1 and Foxc2, are required for arterial specification
and lymphatic sprouting during vascular development. Dev. Biol. 294, 458-470.
Shih, S. C. and Smith, L. E. (2005). Quantitative multi-gene transcriptional profiling
using real-time PCR with a master template. Exp. Mol. Pathol. 79, 14-22.
Siegenthaler, J. A., Ashique, A. M., Zarbalis, K., Patterson, K. P., Hecht, J. H.,
Kane, M. A., Folias, A. E., Choe, Y., May, S. R., Kume, T. et al. (2009). Retinoic
acid from the meninges regulates cortical neuron generation. Cell 139, 597-609.
Smith, R. S., Zabaleta, A., Kume, T., Savinova, O. V., Kidson, S. H., Martin, J. E.,
Nishimura, D. Y., Alward, W. L., Hogan, B. L. and John, S. W. (2000).
Haploinsufficiency of the transcription factors FOXC1 and FOXC2 results in aberrant
ocular development. Hum. Mol. Genet. 9, 1021-1032.
Stenman, J. M., Rajagopal, J., Carroll, T. J., Ishibashi, M., McMahon, J. and
McMahon, A. P. (2008). Canonical Wnt signaling regulates organ-specific assembly
and differentiation of CNS vasculature. Science 322, 1247-1250.
Stenzel, D., Nye, E., Nisancioglu, M., Adams, R. H., Yamaguchi, Y. and Gerhardt,
H. (2009). Peripheral mural cell recruitment requires cell-autonomous heparan
sulfate. Blood 114, 915-924.
Stigliano, I., Puricelli, L., Filmus, J., Sogayar, M. C., Bal de Kier Joffe´, E. and
Peters, M. G. (2009). Glypican-3 regulates migration, adhesion and actin
cytoskeleton organization in mammary tumor cells through Wnt signaling
modulation. Breast Cancer Res. Treat. 114, 251-262.
Sundberg, C., Kowanetz, M., Brown, L. F., Detmar, M. and Dvorak, H. F. (2002).
Stable expression of angiopoietin-1 and other markers by cultured pericytes:
phenotypic similarities to a subpopulation of cells in maturing vessels during later
stages of angiogenesis in vivo. Lab. Invest. 82, 387-401.
Suri, C., Jones, P. F., Patan, S., Bartunkova, S., Maisonpierre, P. C., Davis, S., Sato,
T. N. and Yancopoulos, G. D. (1996). Requisite role of angiopoietin-1, a ligand for
the TIE2 receptor, during embryonic angiogenesis. Cell 87, 1171-1180.
Suri, C., McClain, J., Thurston, G., McDonald, D. M., Zhou, H., Oldmixon, E. H.,
Sato, T. N. and Yancopoulos, G. D. (1998). Increased vascularization in mice
overexpressing angiopoietin-1. Science 282, 468-471.
Thurston, G., Suri, C., Smith, K., McClain, J., Sato, T. N., Yancopoulos, G. D. and
McDonald, D. M. (1999). Leakage-resistant blood vessels in mice transgenically
overexpressing angiopoietin-1. Science 286, 2511-2514.
Vivatbutsiri, P., Ichinose, S., Hyto¨nen, M., Sainio, K., Eto, K. and Iseki, S. (2008).
Impaired meningeal development in association with apical expansion of calvarial
bone osteogenesis in the Foxc1 mutant. J. Anat. 212, 603-611.
Wang, J., Ray, P. S., Sim, M. S., Zhou, X. Z., Lu, K. P., Lee, A. V., Lin, X., Bagaria,
S. P., Giuliano, A. E. and Cui, X. (2012). FOXC1 regulates the functions of human
basal-like breast cancer cells by activating NF-kB signaling. Oncogene 31, 4798-
4802.
Winkler, E. A., Bell, R. D. and Zlokovic, B. V. (2011). Central nervous system
pericytes in health and disease. Nat. Neurosci. 14, 1398-1405.
Zarbalis, K., Siegenthaler, J. A., Choe, Y., May, S. R., Peterson, A. S. and Pleasure,
S. J. (2007). Cortical dysplasia and skull defects in mice with a Foxc1 allele reveal the
role of meningeal differentiation in regulating cortical development. Proc. Natl. Acad.
Sci. USA 104, 14002-14007.
Zhou, Y., Kato, H., Asanoma, K., Kondo, H., Arima, T., Kato, K., Matsuda, T. and
Wake, N. (2002). Identification of FOXC1 as a TGF-beta1 responsive gene and its
involvement in negative regulation of cell growth. Genomics 80, 465-472.
Foxc1 and brain pericytes 659
B
io
lo
g
y
O
p
e
n
